Table 1: Baseline patient characteristics.

Disease characteristicNumber of Patients (%)

Stage
 T10 (0)
 T219 (32)
 T3 41 (68)

Gleason score
 2-618 (30)
 727 (45)
 8–1015 (25)

Presenting PSA (μg/L)
 <1012 (20)
 10–2014 (23)
 >2034 (57)